StonvexLoading…
StonvexStonvexStonvexCore line items from VTEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $240.52M | $226.66M | $200.83M |
Operating Income | $18.11M | $7.39M | $-14.04M |
Net Income | $20.01M | $15.82M | $-15.85M |
EPS (Diluted) | $0.11 | $0.08 | $-0.09 |
Total Assets | $346.63M | $362.11M | $341.14M |
Total Liabilities | Not available | Not available | Not available |
Cash & Equivalents | $15.74M | $18.67M | $28.04M |
Free Cash Flow OCF − CapEx | $32.33M | $23.89M | $4.93M |
Shares Outstanding | 185.11K | 192.33K | 186.37K |